AKT1 and melanoma: Using cell-free, biophysical, computational, cell-based, and in vivo melanoma xenograft models, Jung et al. reported that acacetin inhibited PI3K activity, suppressed Akt phosphorylation and significantly regressed SK-MEL-28 melanoma tumor growth in vivo, suggesting an anti-melanoma agent [124].